Cushing’s Syndrome: Complication of Triamcinolone Injection for Urethral Strictures in Children
- 1 June 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 123 (6) , 932-933
- https://doi.org/10.1016/s0022-5347(17)56200-x
Abstract
Two cases of Cushing''s syndrome are reported following intralesional triamcinolone acetonide injections of urethral strictures in children are reported. The pharmacology of triamcinolone and its 2 parenteral forms, triamcinolone acetonide and triamcinolone diacetate, is discussed. The short-acting triamcinolone diacetate at 4 wk intervals with dosage adjusted to age is recommended for children. In adults either type of triamcinolone may be used but triamcinolone acetonide should be given at 6 wk intervals.This publication has 13 references indexed in Scilit:
- Fluorinated Corticosteroid Toxicity in InfantsAmerican Journal of Ophthalmology, 1977
- HYPERTROPHIC SCARS AND KELOIDS A Collective ReviewPlastic and Reconstructive Surgery, 1974
- The Treatment of Urethral Stricture: Transurethral Injection of TriamcinoloneJournal of Urology, 1972
- Effect of Long-Acting Parenteral Corticosteroids on Adrenal FunctionArchives of Dermatology, 1969
- The Treatment of Hypertrophic Scar, Keloid and Scar Contracture by Triamcinolone AcetonidePlastic and Reconstructive Surgery, 1966
- TRIAMCINOLONE THERAPY IN THE ADRENOGENITAL SYNDROMEPediatrics, 1961
- Uses of Corticosteroids in Urologic PracticeJournal of Urology, 1959
- Urethral Stricture Following Transurethral Resection of the ProstateJournal of Urology, 1958
- Local Injections of Hydrocortisone as a New and Effective Treatment for Strictures of the Urethra and MeatusNew England Journal of Medicine, 1955